(Q50236014)

28 February 2018

meta-analysis

0 references

title

Effects of metformin treatment on blood leptin and ghrelin levels in patients with type 2 diabetes mellitus. (English)

1 reference

28 February 2018

1 reference

1 reference

Satoshi Ida

1

1 reference

28 February 2018

Kazuya Murata

series ordinal

2

1 reference

28 February 2018

Ryutaro Kaneko

series ordinal

3

1 reference

28 February 2018

publication date

5 July 2016

1 reference

28 February 2018

published in

Journal of diabetes

1 reference

28 February 2018

volume

9

1 reference

28 February 2018

issue

5

1 reference

28 February 2018

page(s)

526-535

1 reference

28 February 2018

Prevalence of diabetes and pre-diabetes among workers: Japan Epidemiology Collaboration on Occupational Health Study.

cites work

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

Effect of intensive glycemic control on cardiovascular outcomes and all-cause mortality in type 2 diabetes: Overview and metaanalysis of five trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

Changes in prevalence of diabetic complications and associated healthcare costs during a 10-year follow-up period among a nationwide diabetic cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

Longitudinal associations between sex, diabetes self-care, and health-related quality of life among youth with type 1 or type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

Oxidative stress and cardiovascular disease in type 2 diabetes: the role of antioxidants and pro-oxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

Relationship between obesity, adipocytokines and inflammatory markers in type 2 diabetes: relevance for cardiovascular risk prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

Effect of plasminogen activator inhibitor-1 in diabetes mellitus and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

Plasma leptin concentration in patients with Type 2 diabetes: relationship to cardiovascular disease risk factors and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

Effects of metformin on markers of oxidative stress and antioxidant reserve in patients with newly diagnosed type 2 diabetes: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

Metabolic and haemodynamic effects of metformin in patients with type 2 diabetes mellitus and hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

Short-term effects of metformin in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

Weight gain in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

Regulation of glucose transport and insulin signaling by troglitazone or metformin in adipose tissue of type 2 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

Leptin and body fat in type 2 diabetes and monodrug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

The effects of gliclazide, metformin, and acarbose on body composition in patients with newly diagnosed type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

Comparative effects of metformin and pioglitazone on omentin and leptin concentrations in patients with newly diagnosed diabetes: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

Treatment with pioglitazone is associated with decreased preprandial ghrelin levels: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

Leptin is a potent anti-diabetic in mice with lipodystrophy and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

Hyperleptinaemia: the missing link in the, metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

Low concentrations of metformin suppress glucose production in hepatocytes through AMP-activated protein kinase (AMPK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

Decreased serum leptin concentrations during metformin therapy in obese women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

Effect of metformin on food intake in obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

Metformin restores leptin sensitivity in high-fat-fed obese rats with leptin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

Metformin inhibits adenosine 5'-monophosphate-activated kinase activation and prevents increases in neuropeptide Y expression in cultured hypothalamic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

Effects of pioglitazone versus glipizide on body fat distribution, body water content, and hemodynamics in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

Metformin and body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

Cardiovascular and hormonal effects of subcutaneous administration of ghrelin, a novel growth hormone-releasing peptide, in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

Ghrelin as a treatment for cardiovascular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

Thiazolidinediones upregulate fatty acid uptake and oxidation in adipose tissue of diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

Intensive glucose control and cardiovascular outcomes in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

Rosiglitazone Treatment Enhances Acute AMP-Activated Protein Kinase-Mediated Muscle and Adipose Tissue Glucose Uptake in High-Fat-Fed Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12445

21 January 2018

Identifiers

DOI

10.1111/1753-0407.12445

1 reference

28 February 2018

PubMed ID

27380451

1 reference

28 February 2018